Bruni, C;
Buch, MH;
Djokovic, A;
De Luca, G;
Dumitru, RB;
Giollo, A;
Galetti, I;
Steelandt, A;
Bratis, K;
Suliman, YA;
et al.
Bruni, C; Buch, MH; Djokovic, A; De Luca, G; Dumitru, RB; Giollo, A; Galetti, I; Steelandt, A; Bratis, K; Suliman, YA; Milinkovic, I; Baritussio, A; Hasan, G; Xintarakou, A; Isomura, Y; Markousis-Mavrogenis, G; Mavrogeni, S; Gargani, L; Caforio, AL; Tschöpe, C; Ristic, A; Plein, S; Behr, E; Allanore, Y; Kuwana, M; Denton, CP; Furst, DE; Khanna, D; Krieg, T; Marcolongo, R; Pepe, A; Distler, O; Sfikakis, P; Seferovic, P; Matucci-Cerinic, M
(2023)
Consensus on the assessment of systemic sclerosis-associated primary heart involvement: World Scleroderma Foundation/Heart Failure Association guidance on screening, diagnosis, and follow-up assessment.
J Scleroderma Relat Disord, 8 (3).
pp. 169-182.
ISSN 2397-1991
https://doi.org/10.1177/23971983231163413
SGUL Authors: Behr, Elijah Raphael
|
Microsoft Word (.doc)
Accepted Version
Available under License ["licenses_description_publisher" not defined].
Download (180kB)
|
Abstract
INTRODUCTION: Heart involvement is a common problem in systemic sclerosis. Recently, a definition of systemic sclerosis primary heart involvement had been proposed. Our aim was to establish consensus guidance on the screening, diagnosis and follow-up of systemic sclerosis primary heart involvement patients. METHODS: A systematic literature review was performed to investigate the tests used to evaluate heart involvement in systemic sclerosis. The extracted data were categorized into relevant domains (conventional radiology, electrocardiography, echocardiography, cardiac magnetic resonance imaging, laboratory, and others) and presented to experts and one patient research partner, who discussed the data and added their opinion. This led to the formulation of overarching principles and guidance statements, then reviewed and voted on for agreement. Consensus was attained when the mean agreement was ⩾7/10 and of ⩾70% of voters. RESULTS: Among 2650 publications, 168 met eligibility criteria; the data extracted were discussed over three meetings. Seven overarching principles and 10 guidance points were created, revised and voted on. The consensus highlighted the importance of patient counseling, differential diagnosis and multidisciplinary team management, as well as defining screening and diagnostic approaches. The initial core evaluation should integrate history, physical examination, rest electrocardiography, trans-thoracic echocardiography and standard serum cardiac biomarkers. Further investigations should be individually tailored and decided through a multidisciplinary management. The overall mean agreement was 9.1/10, with mean 93% of experts voting above 7/10. CONCLUSION: This consensus-based guidance on screening, diagnosis and follow-up of systemic sclerosis primary heart involvement provides a foundation for standard of care and future feasibility studies that are ongoing to support its application in clinical practice.
Item Type: |
Article
|
Additional Information: |
Bruni, C; Buch, MH; Djokovic, A; De Luca, G; Dumitru, RB; Giollo, A; Galetti, I; Steelandt, A; Bratis, K; Suliman, YA; et al., Consensus on the assessment of systemic sclerosis-associated primary heart involvement: World Scleroderma Foundation/Heart Failure Association guidance on screening, diagnosis, and follow-up assessment, Journal of Scleroderma and Related Disorders (Volume 8, Issue 3) pp. 169 - 182. Copyright © 2023 (The Author(s)). DOI: 10.1177/23971983231163413 |
Keywords: |
Systemic sclerosis, cardiac involvement, consensus guidance, diagnosis, follow-up, screening, Systemic sclerosis, cardiac involvement, consensus guidance, screening, diagnosis, follow-up |
SGUL Research Institute / Research Centre: |
Academic Structure > Molecular and Clinical Sciences Research Institute (MCS) |
Journal or Publication Title: |
J Scleroderma Relat Disord |
ISSN: |
2397-1991 |
Language: |
eng |
Dates: |
Date | Event |
---|
October 2023 | Published | 3 April 2023 | Published Online | 24 February 2023 | Accepted |
|
Publisher License: |
Publisher's own licence |
Projects: |
Project ID | Funder | Funder ID |
---|
UNSPECIFIED | World Scleroderma Foundation | http://dx.doi.org/10.13039/501100023833 | UNSPECIFIED | Heart Failure Association of the European Society of Cardiology | UNSPECIFIED | UNSPECIFIED | Italian Ministry of University and Research | UNSPECIFIED |
|
PubMed ID: |
37744047 |
Web of Science ID: |
WOS:000962346300001 |
|
Go to PubMed abstract |
URI: |
https://openaccess.sgul.ac.uk/id/eprint/115858 |
Publisher's version: |
https://doi.org/10.1177/23971983231163413 |
Statistics
Item downloaded times since 20 Nov 2023.
Actions (login required)
|
Edit Item |